- ABOUT US
- SERVICES
- FACILITY
- CONDITIONS
- Age-Related Macular Degeneration
- Birdshot Retinochoroidopathy
- Branch Retinal Artery Occlusion
- Branch Retinal Vein Occlusion
- Central Retinal Artery Occlusion
- Central Retinal Vein Occlusion
- Central Serious Retinopathy
- Coats' Disease
- Cystoid Macular Edema
- Cytomegalovirus Retinitis
- Detached and Torn Retina
- Diabetic Eye Disease
- Diabetic Retinopathy
- Flashes & Floaters
- Lattice Degeneration
- Macular Dystrophy
- Macular Edema
- Macular Hole
- Nonproliferative Diabetic Retinopathy
- Ocular Histoplasmosis Syndrome
- Proliferative Diabetic Retinopathy
- Rentinitis Pigmentosa
- Rentinoblastoma
- Rentinopathy of Prematurity
- Rentinoschsis
- Stargardt's Disease
- Toxoplasmosis
- Uveitis
- Vitrectomy Surgery
- Vitreous Hemorrhage
- PATIENT CARE
- CONTACT US
change text size:
Press Room
Hawaii Practice Selected To Hold Clinical Trials For Residents Suffering From Wet Age-Related Macular Degeneration
January 21, 2009
There is new hope for Hawaii residents suffering from wet Age-Related Macular Degeneration (AMD), the leading cause of blindness among the elderly. That’s because the Retina Institute of Hawaii has been selected as one of 26 sites in the United States to hold clinical trials for NeoVista’s Novel Wet AMD Therapy. The clinical trial is now open for qualifying patients.
Current AMD treatment involves monthly visits, where patients receive targeted injections in the infected area. NeoVista’s Novel Wet AMD Therapy offers a more aggressive option for patients, with a one-time treatment of a targeted dose of beta radiation to leaking blood vessels and two injections of anti-vascular endothelial growth factor.
Wet AMD occurs when blood vessels grow underneath the eye's retina and macula, destroying or distorting vision. As it primarily infects the elderly, it is often difficult for sufferers to frequent their doctor’s office to receive the current standard treatment of monthly injections.
The Retina Institute of Hawaii has already performed a number of the NeoVista Novel Wet AMD procedures on patients with positive results. For more information or to schedule a consultation, please call (808) 955-0255.
About Retina Institute of Hawaii
The Retina Institute of Hawaii is an Oahu-based ophthalmic practice founded in 2001 by Dr. Michael D. Bennett. The institute specializes in the medical and surgical management of sight threatening diseases that affect the retina, vitreous and macula.
